Literature DB >> 7039661

A technique for rapid isolation of bone marrow mononuclear cells using Ficoll-Metrizoate and the IBM 2991 blood cell processor.

M J Gilmore, H G Prentice, H A Blacklock, G Janossy, A V Hoffbrand.   

Abstract

Marrow from seven normal donors and patients has been layered onto Ficoll-Metrizoate (FM) under pressure in the IBM 2991 blood cell processor to isolate the mononuclear cell (MNC) population prior to allogeneic transplantation or cryopreservation. This separation method, which takes less than 90 min, is a further development since our previous report detailing the use of the IBM 2991 to produce a concentrated marrow 'buffy coat' for infusion (Gilmore & Prentice, 1981). By adding FM to the system, marrow stem cells are further concentrated in a small volume with removal of unwanted granulocytes and red blood cells. This facilitates in in vitro treatment of marrow with monoclonal antibodies (Granger et al. 1982) or drugs, for either the selective elimination of malignant cells prior to autologous bone marrow transplantation (BMT), or T lymphocytes in an attempt to prevent graft versus host disease (GvHD) in allogeneic BMT. Five of the seven marrows processed by this procedure have thus far been infused into lethally irradiated recipients with engraftment (allogeneic); the other two marrows have been cryopreserved.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7039661     DOI: 10.1111/j.1365-2141.1982.tb01962.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

Review 1.  ACP Broadsheet No 134: December 1992. How to harvest bone marrow for transplantation.

Authors:  R Jones; A K Burnett
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

2.  Comparison of five methods for concentrating progenitor cells in human marrow transplantation.

Authors:  A Dragani; A Angelini; A Iacone; D D'Antonio; G Torlontano
Journal:  Blut       Date:  1990-05

3.  The optimization of large-scale density gradient isolation of human islets.

Authors:  G S Robertson; D R Chadwick; H Contractor; R F James; N J London
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

Review 4.  In vitro chemoseparation as part of autologous bone marrow transplantation (ABMT) in hematologic malignancy.

Authors:  M Körbling; W Hunstein
Journal:  Blut       Date:  1984-04

5.  CFU-c enrichment from human bone marrow using a discontinuous Percoll gradient and soybean agglutinin in comparison with Ficoll-paque.

Authors:  G M Georgiou; D M Roberton; W M Ellis; B J Shen; H Ekert; C S Hosking
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

6.  T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow.

Authors:  G Janossy; H G Prentice; J P Grob; K Ivory; N Tidman; J Grundy; M Favrot; M K Brenner; D Campana; H A Blacklock
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

7.  The role of monoclonal antibodies in the prevention of graft versus host disease.

Authors:  G Janossy; H G Prentice; A V Hoffbrand; H A Blacklock; K Ivory; M J Gilmore
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

8.  Autologous Bone Marrow-Derived Stem Cell Therapy for Asherman's Syndrome and Endometrial Atrophy: A 5-Year Follow-up Study.

Authors:  Neeta Singh; Bhawani Shekhar; Sujata Mohanty; Sunesh Kumar; Tulika Seth; Bhavana Girish
Journal:  J Hum Reprod Sci       Date:  2020-04-07

9.  Autologous stem cell transplantation in refractory Asherman's syndrome: A novel cell based therapy.

Authors:  Neeta Singh; Sujata Mohanty; Tulika Seth; Meenakshi Shankar; Sruthi Bhaskaran; Sona Dharmendra
Journal:  J Hum Reprod Sci       Date:  2014-04

10.  A subset of bone marrow stromal cells regulate ATP-binding cassette gene expression via insulin-like growth factor-I in a leukemia cell line.

Authors:  Nadia Benabbou; Pezhman Mirshahi; Camille Bordu; Anne-Marie Faussat; Ruoping Tang; Amu Therwath; Jeannette Soria; Jean-Pierre Marie; Massoud Mirshahi
Journal:  Int J Oncol       Date:  2014-07-29       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.